Skip to main content
Top
Published in: Journal of General Internal Medicine 12/2014

01-12-2014 | Clinical Practice: Clinical Images

An Unusual Rash in a Middle-Aged Man

Authors: Ambarish Pandey, MD, Ariel Aday, MD

Published in: Journal of General Internal Medicine | Issue 12/2014

Login to get access

Excerpt

A 46-year-old Caucasian male with a history of poorly controlled type II diabetes mellitus (DM) and hypertriglyceridemia presented with painless, non-pruritic bumps on his bilateral arms and knees for two weeks. Four weeks previously, the patient had been started on mirtazapine for post-traumatic stress disorder. He denied any past or family history of such rashes. On examination, his skin was remarkable for grouped pink to yellow, well-defined papules on the extensor surfaces of his elbows and knees (Fig. 1). The patient’s laboratory tests showed hyperglycemia (400 mg/dl) and severe hypertriglyceridemia (>3000 mg/dl). Based on his examination and laboratory findings, a diagnosis of eruptive xanthomas in the setting of severe hypertriglyceridemia was made.
Literature
1.
go back to reference Parker F, Bagdade JD, Odland JF, Bierman EL. Evidence for the chylomicron origin of lipids accumulating in diabetic eruptive xanthoma: a correlative lipid biochemical, histochemical, and electron microscopic study. J Clin Invest. 1970;49(12):2172–87.PubMedCentralPubMedCrossRef Parker F, Bagdade JD, Odland JF, Bierman EL. Evidence for the chylomicron origin of lipids accumulating in diabetic eruptive xanthoma: a correlative lipid biochemical, histochemical, and electron microscopic study. J Clin Invest. 1970;49(12):2172–87.PubMedCentralPubMedCrossRef
2.
go back to reference Cruz PD Jr, East C, Bergstresser PR. Dermal, subcutaneous, and tendon xanthomas: diagnostic markers for specific lipoprotein disorders. J Am Acad Dermatol. 1988;19(1 pt 1):95–111.PubMedCrossRef Cruz PD Jr, East C, Bergstresser PR. Dermal, subcutaneous, and tendon xanthomas: diagnostic markers for specific lipoprotein disorders. J Am Acad Dermatol. 1988;19(1 pt 1):95–111.PubMedCrossRef
3.
go back to reference Chang HY, Ridky TW, Kimball AB, Hughes E, Oro AE. Eruptive xanthomas associated with olanzapine use. Arch Dermatol. 2003;139(8):1045–8.PubMedCrossRef Chang HY, Ridky TW, Kimball AB, Hughes E, Oro AE. Eruptive xanthomas associated with olanzapine use. Arch Dermatol. 2003;139(8):1045–8.PubMedCrossRef
Metadata
Title
An Unusual Rash in a Middle-Aged Man
Authors
Ambarish Pandey, MD
Ariel Aday, MD
Publication date
01-12-2014
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 12/2014
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-014-2918-6

Other articles of this Issue 12/2014

Journal of General Internal Medicine 12/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine